FRIDAY, May 1, 2026 (HealthDay News) -- LFSPRO, a Mendelian, family history-based model that estimates an individual's probability of harboring a deleterious TP53 variant, shows superior ...
In a prospective validation study, researchers at The University of Texas MD Anderson Cancer Center have demonstrated that a new mathematical model called LFSPRO was effective in supporting genetic ...
In a prospective validation study, researchers at The University of Texas MD Anderson Cancer Center demonstrated that a new mathematical model, called LFSPRO, was effective in supporting genetic ...
Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease For prediction of deleterious TP53 mutations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results